MOTS-c Quick Start
MOTS-c (Mitochondrial Open-reading-frame of the Twelve S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial DNA. It is studied as a regulator of metabolic homeostasis and an "exercise-mimetic," with research focused on insulin sensitivity, fat metabolism, and mitochondrial function.
This guide is an educational research reference. It does not diagnose, treat, or prescribe, and is not medical advice. Consult a licensed clinician before considering any compound.
MOTS-c Dosing Protocols
The injectable (subcutaneous) and nasal-spray formats are documented as two separate protocols. Community-derived planning typically uses several doses per week. Ranges are research-planning references, not personal dosing recommendations.
Injection — Subcutaneous
| Band | Per dose | Frequency |
|---|---|---|
| Low | 5 mg | 3× weekly |
| Standard | 10 mg | 3–5× weekly |
Nasal Spray
| Band | Per dose | # of sprays | Frequency |
|---|---|---|---|
| Low | 5 mg | 7 sprays | 3× weekly |
| Standard | 10 mg | 13 sprays | 3–5× weekly |
MOTS-c Reconstitution Guide
MOTS-c ships as a lyophilized powder. The BAC water volume sets the concentration and draw volume for the injectable vial. Nasal sprays ship pre-mixed and ready to use.
Injection
| BAC | Conc. | 5 mg |
|---|---|---|
| 2 mL | 20 mg/mL | 0.25 mL · 25 u |
| 3 mL | 13.3 mg/mL | 0.375 mL · 37.5 u |
Vial holds up to ~3 mL; 2 mL is the default. Units are U-100.
Reconstitution steps
- Inspect the vial. Confirm label and intact powder.
- Wipe the stoppers. Alcohol swab on both vials.
- Draw BAC water. 2 mL into the injectable vial.
- Inject down the wall. Release water slowly down the inside wall, not onto the powder.
- Swirl, do not shake. Roll gently until clear.
- Refrigerate. Store at 2–8 °C; do not freeze.
How to use the nasal spray
- Prime first use. Pump 2–3 sprays into a tissue until a fine, even mist appears.
- Position. Tilt the head slightly forward; insert the tip just inside one nostril, aimed slightly outward toward the ear — not at the septum.
- Spray and breathe. Press once while breathing in gently; do not sniff hard, which sends the solution down the throat instead of onto the mucosa.
- Alternate nostrils. For multi-spray doses, switch nostrils each spray to spread absorption and limit irritation.
- Count per the protocol. Use the sprays-per-dose shown above; if a dose isn't a whole number, round up.
- Between uses. Wipe the tip, recap, and refrigerate.
How MOTS-c Works
MOTS-c is encoded in mitochondrial DNA and acts as a signaling peptide between mitochondria and the cell nucleus. Research reports that it activates AMP-activated protein kinase (AMPK) — a master regulator of cellular energy — and translocates to the nucleus under metabolic stress to regulate gene expression. Downstream, it has been linked in animal models to improved insulin sensitivity, glucose handling, and exercise capacity, which is why it is described as an exercise-mimetic.
AMPK activation
Engages the cell's primary energy-sensing pathway in research models.
Metabolic regulation
Animal data report improved insulin sensitivity and glucose metabolism.
Nuclear signaling
Translocates to the nucleus under stress to influence metabolic genes.
Open question
Human efficacy and long-term safety are not established in trials.
Who Should Avoid MOTS-c
Pregnancy & lactation
No human reproductive safety data.
Diabetes / glucose-active meds
Reported insulin-sensitizing effects mean those on glucose-lowering drugs should review with a clinician.
Hypoglycemia risk
Monitor for low blood sugar given metabolic activity.
Anyone seeking a treatment
MOTS-c is a research compound, not a medical treatment.
MOTS-c Side Effects & Safety
Limited human data
Most safety information is preclinical; human controlled data is sparse.
Injection-site reactions
Mild local reactions can occur; rotate sites.
Blood-sugar effects
Given AMPK/insulin activity, monitor for hypoglycemia, especially with other agents.
Quality-control risk
Verify identity and purity against a Certificate of Analysis.
Timeline & What to Monitor
| Timeframe | Commonly tracked | Notes |
|---|---|---|
| Week 1–2 | Tolerability, energy self-report | Subjective; no validated peptide-specific marker. |
| Week 2–6 | Metabolic context (glucose, body composition) | General markers only; interpret with a clinician. |
| Ongoing | Blood sugar | Relevant given insulin-sensitizing activity. |
Research Evidence Context
Discovery
Identified as a mitochondrial-derived peptide regulating metabolic homeostasis (Lee et al., 2015).
Metabolic models
Animal studies report improved insulin sensitivity and exercise capacity.
Aging research
Studied in the context of declining MOTS-c levels with age.
Open question
No large human RCT; planning ranges are community-derived.
Storage & Handling
| State | Storage | Notes |
|---|---|---|
| Lyophilized (powder) | −20 °C long-term; fridge short-term | More stable than reconstituted solution. |
| Reconstituted (liquid) | 2–8 °C | Use within ~3–4 weeks; do not freeze. |
| Appearance | Clear, colorless | Discard cloudy or particulate solutions. |
Mistakes & Troubleshooting
- Too many sprays feel impractical. The injection is the compact route for MOTS-c; the spray needs several sprays per mg-range dose.
- Wrong BAC volume. Recalculate concentration; injection assumes 2 mL, spray assumes 5 mL.
- Light-headedness. Consider blood-sugar effects; review with a clinician if persistent.
- Left out overnight. Treat reconstituted solution as compromised and discard.
MOTS-c in Context
| Feature | MOTS-c | Other mitochondrial peptides |
|---|---|---|
| Origin | Mitochondrial DNA (16 aa) | e.g., Humanin, SS-31 (different targets) |
| Focus | Metabolism, AMPK, exercise-mimetic | Cytoprotection / mitochondrial function |
| Cadence | 3–5× weekly | Varies |
Frequently Asked Questions
What is MOTS-c?
A 16-amino-acid mitochondrial-derived peptide studied as a metabolic regulator and exercise-mimetic.
How is the injection dosed vs the nasal spray?
Separate protocols. Injection commonly references 5–10 mg, 3–5× weekly. Because MOTS-c doses are in the milligram range, the spray uses a concentrated 5 mL fill (0.8 mg/spray), so 5 mg ≈ 7 sprays and 10 mg ≈ 13 sprays — the injection is the more compact route.
How is MOTS-c reconstituted?
For injection, 40 mg in 2 mL BAC water gives 20 mg/mL, so 5 mg = 0.25 mL = 25 units. The spray ships pre-mixed and delivers 0.8 mg per spray.
Does MOTS-c affect blood sugar?
In research models it activates AMPK and improves insulin sensitivity, so blood-sugar awareness is prudent, especially alongside glucose-lowering agents.
Is this page medical advice?
No. It is an educational research reference and does not diagnose, treat, or prescribe. Consult a licensed clinician before considering any compound.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab (2015).
- Reynolds JC, et al. MOTS-c, exercise, and metabolic regulation. Nat Commun (2021).
- Kim KH, et al. MOTS-c and AMPK signaling. Cell Metab / J Biol Chem (review).
- Merry TL, et al. Mitochondrial-derived peptides in metabolic health. Am J Physiol (review).